1. Home
  2. AMGN
  3. AMGN News

Latest Amgen Inc. (AMGN) News on October 9, 2025

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab
AMGN

GlobeNewswire

13 hours ago

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
AMGN

Zacks

a day ago

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges
AMGN

StockStory

2 days ago

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges

Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?
AMGN

Simply Wall St.

2 days ago

Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?

Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%
AMGN

Zacks

2 days ago

Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%

/C O R R E C T I O N -- Amgen/
AMGN

PR Newswire

3 days ago

/C O R R E C T I O N -- Amgen/

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why
AMGN

Zacks

3 days ago

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online
AMGN

GuruFocus.com

3 days ago

Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online

Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts
AMGN

The Wall Street Journal

3 days ago

Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts

AMGN

MT Newswires

3 days ago

GoodRx Expands Affordable Access to Cholesterol Drug Repatha

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035
AMGN

GlobeNewswire

3 days ago

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035

AMGN

MT Newswires

3 days ago

Amgen Introduces Direct-to-Patient Access for Repatha in US

Here's Why Amgen (AMGN) is a Strong Value Stock
AMGN

Zacks

3 days ago

Here's Why Amgen (AMGN) is a Strong Value Stock

4 Reasons to Buy Amgen Stock Right Now
AMGN

Motley Fool

5 days ago

4 Reasons to Buy Amgen Stock Right Now

Amgen’s Phase III data supports FDA label expansion of Repatha
AMGN

Clinical Trials Arena

6 days ago

Amgen’s Phase III data supports FDA label expansion of Repatha

Amgen’s Phase III data supports FDA label expansion of Repatha
AMGN

Pharmaceutical Technology

6 days ago

Amgen’s Phase III data supports FDA label expansion of Repatha

Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial
AMGN

Clinical Trials Arena

6 days ago

Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial

September in Review: 11 Top Health Press Releases
AMGN

PR Newswire

6 days ago

September in Review: 11 Top Health Press Releases

AMGN

Argus Research

7 days ago

Analyst Report: Regeneron Phars, Inc

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise
AMGN

Simply Wall St.

7 days ago

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise

AMGN

MT Newswires

7 days ago

Amgen Says Dual Primary Endpoints Met in Phase 3 Cardiovascular Events Prevention Trial of Repatha

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
AMGN

Zacks

7 days ago

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term

Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen
AMGN

StockStory

7 days ago

Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen

LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
AMGN

PR Newswire

7 days ago

LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS

Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done
AMGN

Investor's Business Daily

7 days ago

Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer
AMGN

Motley Fool

8 days ago

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer

Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs
AMGN

Insider Monkey

8 days ago

Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs

Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion
AMGN

Insider Monkey

8 days ago

Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion

AMGN

Morningstar Research

8 days ago

Analyst Report: Amgen Inc.

Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks
AMGN

Benzinga

8 days ago

Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks

S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown
AMGN

MT Newswires

8 days ago

S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi
AMGN

GlobeNewswire

8 days ago

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff
AMGN

Investor's Business Daily

8 days ago

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff

Immatics Appoints Venkat Ramanan as Chief Financial Officer
AMGN

GlobeNewswire

8 days ago

Immatics Appoints Venkat Ramanan as Chief Financial Officer

AMGN

MT Newswires

9 days ago

Drug Manufacturers Help Push US Equity Indexes Higher While Government Shutdown Looms

Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.
AMGN

Barrons.com

9 days ago

Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
AMGN

StockStory

9 days ago

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)
AMGN

Insider Monkey

9 days ago

Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)

Amgen to expand US drug production with $650M investment
AMGN

Manufacturing Dive

9 days ago

Amgen to expand US drug production with $650M investment

Amgen to invest $650m in US manufacturing network expansion
AMGN

Pharmaceutical Technology

11 days ago

Amgen to invest $650m in US manufacturing network expansion

Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency
AMGN

Insider Monkey

11 days ago

Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency

Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs
AMGN

Insider Monkey

11 days ago

Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs

Expansion of U.S. Manufacturing and Tezspire Approval Might Change the Case for Investing in Amgen (AMGN)
AMGN

Simply Wall St.

12 days ago

Expansion of U.S. Manufacturing and Tezspire Approval Might Change the Case for Investing in Amgen (AMGN)

GLP-1 race evolves as Amgen & weight-loss pills enter the scene
AMGN

Yahoo Finance Video

13 days ago

GLP-1 race evolves as Amgen & weight-loss pills enter the scene

Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.
AMGN

Barrons.com

13 days ago

Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.

All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street
AMGN

Fortune

13 days ago

All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street

These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More
AMGN

Barrons.com

13 days ago

These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More

AMGN

MT Newswires

13 days ago

Sector Update: Health Care Stocks Gain Late Afternoon

AMGN

MT Newswires

13 days ago

Sector Update: Health Care Stocks Rise Friday Afternoon

AMGN

MT Newswires

13 days ago

US Equity Indexes Rise as Investors Assess Latest Inflation Data

AMGN

MT Newswires

13 days ago

Sector Update: Health Care

AMGN

MT Newswires

13 days ago

US Equity Indexes Rise in Midday Trading

AMGN

ACCESS Newswire

13 days ago

CASI Pharmaceuticals Appoints James Huang to Board of Directors

AMGN

MT Newswires

13 days ago

Amgen to Invest $650 Million in Expanding US Manufacturing Network

AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
AMGN

PR Newswire

13 days ago

AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS

Eli Lilly, Pfizer Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.
AMGN

Barrons.com

13 days ago

Eli Lilly, Pfizer Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.

US, European pharma stocks steady after Trump's tariff move, Asia slips
AMGN

Reuters

14 days ago

US, European pharma stocks steady after Trump's tariff move, Asia slips

Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?
AMGN

Insider Monkey

14 days ago

Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?

Dr. Robert Lenz Joins Unlearn as Strategic Advisor
AMGN

Business Wire

14 days ago

Dr. Robert Lenz Joins Unlearn as Strategic Advisor

Amgen (AMGN) Dips More Than Broader Market: What You Should Know
AMGN

Zacks

15 days ago

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

AMGN

MT Newswires

15 days ago

Citigroup Adjusts Price Target on Amgen to $315 From $310, Maintains Neutral Rating

Pharma’s next generation of blockbuster antibodies takes a ‘more is better’ approach
AMGN

Pharma Voice

16 days ago

Pharma’s next generation of blockbuster antibodies takes a ‘more is better’ approach

A Once-in-a-Decade Opportunity: 10 Billion Reasons to Pay Attention to This Monster Quantum Computing Company (Hint: Not IonQ)
AMGN

Motley Fool

16 days ago

A Once-in-a-Decade Opportunity: 10 Billion Reasons to Pay Attention to This Monster Quantum Computing Company (Hint: Not IonQ)

Amgen (NASDAQ:AMGN) jumps 4.2% this week, though earnings growth is still tracking behind three-year shareholder returns
AMGN

Simply Wall St.

16 days ago

Amgen (NASDAQ:AMGN) jumps 4.2% this week, though earnings growth is still tracking behind three-year shareholder returns

Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?
AMGN

Zacks

17 days ago

Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?

Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors
AMGN

Business Wire

17 days ago

Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors

Why Amgen (AMGN) Stock Is Trading Up Today
AMGN

StockStory

20 days ago

Why Amgen (AMGN) Stock Is Trading Up Today

AMGN

MT Newswires

20 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

AMGN

MT Newswires

20 days ago

Sector Update: Health Care Stocks Mixed Friday Afternoon

AMGN

MT Newswires

20 days ago

Sector Update: Health Care

EMA Backs Amgen Drug For Rare Autoimmune Disorder
AMGN

Benzinga

20 days ago

EMA Backs Amgen Drug For Rare Autoimmune Disorder

AMGN

MT Newswires

20 days ago

Amgen's Uplizna Receives European Human Medicines Committee Recommendation for IgG4-Related Disease

AMGN

MT Newswires

20 days ago

Organon, Shanghai Henlius Say EU Approves Denosumab Biosimilars

J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why
AMGN

Zacks

21 days ago

J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why

AMGN

MT Newswires

21 days ago

Alnylam Joins Alliance for Genomic Discovery

Why Amgen (AMGN) is a Top Value Stock for the Long-Term
AMGN

Zacks

22 days ago

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Ollin debuts with $100M and plans to challenge top-selling eye drugs
AMGN

BioPharma Dive

23 days ago

Ollin debuts with $100M and plans to challenge top-selling eye drugs

What Do Analysts Think About Amgen Inc. (AMGN)?
AMGN

Insider Monkey

23 days ago

What Do Analysts Think About Amgen Inc. (AMGN)?

AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?
AMGN

Zacks

23 days ago

AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?

Amgen Insiders Sold US$12m Of Shares Suggesting Hesitancy
AMGN

Simply Wall St.

23 days ago

Amgen Insiders Sold US$12m Of Shares Suggesting Hesitancy

Stock Market Today: Dow Wavers Amid Surprise Retail Sales; Dave & Busters Plunges (Live Coverage)
AMGN

Investor's Business Daily

23 days ago

Stock Market Today: Dow Wavers Amid Surprise Retail Sales; Dave & Busters Plunges (Live Coverage)

Immuneering Appoints Dr. Thomas Schall as Chairman of the Board
AMGN

GlobeNewswire

23 days ago

Immuneering Appoints Dr. Thomas Schall as Chairman of the Board

Why California’s biopharma boom is critical for logistics
AMGN

FreightWaves

24 days ago

Why California’s biopharma boom is critical for logistics

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
AMGN

Zacks

24 days ago

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Samsung Biologics, Amgen and Biocon invest in US pharma sites
AMGN

Manufacturing Dive

24 days ago

Samsung Biologics, Amgen and Biocon invest in US pharma sites

2 Healthcare Dividend Stocks to Buy and Hold
AMGN

Motley Fool

25 days ago

2 Healthcare Dividend Stocks to Buy and Hold

Guggenheim Maintains a Hold on Amgen Inc. (AMGN)
AMGN

Insider Monkey

a month ago

Guggenheim Maintains a Hold on Amgen Inc. (AMGN)

AMGN

Morningstar Research

a month ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

AMGN

Argus Research

a month ago

Analyst Report: AMGEN Inc.

AMGN

Argus Research

a month ago

Market Digest: AMGN, APD, PCG, RL, SJM, DG

Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab
AMGN

Insider Monkey

a month ago

Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab

Amgen (AMGN) And Kyowa Kirin Reveal Initial Results From Rocatinlimab ASCEND Study
AMGN

Simply Wall St.

a month ago

Amgen (AMGN) And Kyowa Kirin Reveal Initial Results From Rocatinlimab ASCEND Study

Prevent Blindness Kicks Off Annual World Sight Day Activities to Raise Awareness, Provide Education on the Importance of Vision Health and Equitable Access to Eye Care
AMGN

PR Newswire

a month ago

Prevent Blindness Kicks Off Annual World Sight Day Activities to Raise Awareness, Provide Education on the Importance of Vision Health and Equitable Access to Eye Care

Kriya, Odyssey secure ‘megarounds’; Amgen boosts R&D leadership
AMGN

BioPharma Dive

a month ago

Kriya, Odyssey secure ‘megarounds’; Amgen boosts R&D leadership

The Bull Case For Amgen (AMGN) Could Change Following Phase 3 Rocatinlimab Data Release
AMGN

Simply Wall St.

a month ago

The Bull Case For Amgen (AMGN) Could Change Following Phase 3 Rocatinlimab Data Release

AMGN

MT Newswires

a month ago

Trump Signs Memorandum to Crack Down on Misleading Direct-to-Consumer Drug Ads

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis
AMGN

Benzinga

a month ago

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis

Amgen and Kyowa Kirin report preliminary outcomes from AD treatment trial
AMGN

Clinical Trials Arena

a month ago

Amgen and Kyowa Kirin report preliminary outcomes from AD treatment trial

Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
AMGN

GlobeNewswire

a month ago

Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis

If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today
AMGN

Motley Fool

a month ago

If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today

Share on Social Networks: